Nutritional status assessment in colorectal cancer patients qualified to systemic treatment

Monika Ziętarska(University of Gdańsk), Sylwia Małgorzewicz(Gdańsk Medical University), Joanna Krawczyk-Lipiec(Medical University of Warsaw), Leszek Kraj(Medical University of Warsaw), Renata Zaucha(Gdańsk Medical University)

Współczesna Onkologia

January 1, 2017

10.5114/wo.2017.68625

Cited by 30

Related Papers

Durvalumab plus Gemcitabine and Cisplatin in Advanced Biliary Tract Cancer

|NEJM Evidence|2022|1.1k

Durvalumab or placebo plus gemcitabine and cisplatin in participants with advanced biliary tract cancer (TOPAZ-1): updated overall survival from a randomised phase 3 study

|The Lancet. Gastroenterology & hepatology|2024|245

Dietary Habits before and during the COVID-19 Epidemic in Selected European Countries

|Nutrients|2021|243

CD34 cell dose in granulocyte colony-stimulating factor–mobilized peripheral blood mononuclear cell grafts affects engraftment kinetics and development of extensive chronic graft-versus-host disease after human leukocyte antigen–identical sibling transplantation

|Blood|2001|227

Role of adipokines in complications related to obesity. A review

|Advances in Medical Sciences|2009|176